Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Pharmaceuticals Invest $291 Billion in the Us in the Face of Tariffs

Summary by Expansión
AstraZeneca is the last to join the ads of J&J, Roche, BMS, Takeda, Lilly, Novartis, AbbVie, Gilead or Merck-MSD to install new R & D factories and centers in the country. Read
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

ExpansiónExpansión

Pharmaceuticals Invest $291 Billion in the Us in the Face of Tariffs

AstraZeneca is the last to join the ads of J&J, Roche, BMS, Takeda, Lilly, Novartis, AbbVie, Gilead or Merck-MSD to install new R & D factories and centers in the country. Read

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Expansión broke the news in on Sunday, August 3, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Johnson & Johnson icon

Johnson & Johnson

United States icon

United States

News
For You
SearchBlindspotLocal